NeuralStudio
NeuralStudio Raises $500M Series E to Transform HealthTech
Quick Facts
NeuralStudio Raises $500M Series E in Latest Funding Round
NeuralStudio has successfully closed a $500M Series E funding round, marking a significant milestone in the company's growth trajectory. The round was led by Insight Partners, with participation from Andreessen Horowitz.
Company Overview
Founded in 2024 and headquartered in Austin, TX, NeuralStudio has established itself in the HealthTech space. Leading clinical decision support system enhancing medical accuracy with AI
With a current valuation of $5B, the company has demonstrated strong market traction and investor confidence.
Investment Details
- Amount Raised: $500M Series E
- Valuation: $5B
- Lead Investor: Insight Partners
Future Outlook
As NeuralStudio moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the healthtech space.
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
